Buscar resultados de ensayos clínicos
Gaucher Disease Type 1 - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1) Condición: Gaucher Disease Type 1 Fecha: 2015-08-21 Intervenciones: Drug: N-acetylcysteine 1800mg NAC twice daily (3600mg/day) orally for approximately 90 days. |
Completed |
Nombre del estudio: Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease Condición: Type 1 Gaucher Disease Fecha: 2006-04-26 Intervenciones: Drug: miglustat miglustat oral capsules 100mg three times daily (TID) |
Not yet recruiting |
Nombre del estudio: Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease Condición: Type 1 Gaucher Disease Fecha: 2016-09-23 Intervenciones: Drug: Elelyso 60 units/kg All patients receive Elelyso 60 units/kg. |
Completed |
Nombre del estudio: Comparison of BMD Measurement by DEXA to BeamMed Speed-of-Sound Measurement at Forearm in Patients With Gaucher Disease Condición: Gaucher Disease Type 1 Fecha: 2014-01-27 Intervenciones: Device: BeamMed Speed-of-Sound bone strength test at forearm BeamMed Speed-of-Sound bone strength test a |
Terminated |
Nombre del estudio: A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101 Condición: Type 1 Gaucher Disease Fecha: 2009-04-02 Intervenciones: Drug: AT2101 225mg (nine 25mg capsules total dose) to be taken by mouth every day for 9 days (Study Days |
Completed |
Nombre del estudio: Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease Condición:
|
Recruiting |
Nombre del estudio: GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 Condición: Gaucher Disease Type 1-Gaucher Disease Type 3 Fecha: 2016-07-20 Intervenciones: Drug: GZ402671 Other Name: Venglustat |
Recruiting |
Nombre del estudio: The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease Condición:
Fecha: 2015-07-28 Intervenciones: Drug: Velaglucerase alfa Enzyme replacement therapy |
Completed |
Nombre del estudio: A Long-Term Extension Study of AT2101 in Type 1 Gaucher Patients Condición:
|